Bayer AG (WAR:BAY) Cyclically Adjusted FCF per Share: zł20.30 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:BAY Bayer AG WAR:BAY
41 GF Score
Price zł212.40
GF Value zł114.86
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Bayer AG Cyclically Adjusted FCF per Share?

Bayer AG WAR:BAY 41 Cyclically Adjusted FCF per Share is zł20.30 as of Jun. 2026. GuruFocus rates WAR:BAY with a GF Score™ of 41/100 and a GF Value™ of zł114.86 (Significantly Overvalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Bayer AG's adjusted free cash flow per share for the three months ended in Jun. 2026 was zł0.130. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is zł20.30 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Bayer AG's average Cyclically Adjusted FCF Growth Rate was -8.50% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -1.00% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 1.60% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 1.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Bayer AG was 6.10% per year. The lowest was -4.20% per year. And the median was 1.10% per year.

As of today (2026-08-21), Bayer AG's current stock price is zł212.40. Bayer AG's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was zł20.30. Bayer AG's Cyclically Adjusted Price-to-FCF of today is 10.46.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Bayer AG was 25.28. The lowest was 3.41. And the median was 10.45.


Bayer AG  (WAR:BAY) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Bayer AG's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=212.40/20.30
=10.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Bayer AG was 25.28. The lowest was 3.41. And the median was 10.45.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Bayer AG Cyclically Adjusted FCF per Share Related Terms


Bayer AG Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Bayer AG's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bayer AG Cyclically Adjusted FCF per Share Chart

Bayer AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 24.25 23.05 22.21

Bayer AG Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.47 21.43 22.21 21.37 20.30

WAR:BAY vs LLY, JNJ, ABBV: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - General subindustry, Bayer AG's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bayer AG Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bayer AG's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Bayer AG's Cyclically Adjusted Price-to-FCF falls into.


WAR:BAY
41GF Score
Bayer AG WAR:BAY
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bayer AG Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bayer AG's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.13/131.3638*131.3638
=0.130

Current CPI (Jun. 2026) = 131.3638.

Bayer AG Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 12.005 101.017 15.611
201612 8.077 101.217 10.483
201703 1.929 101.417 2.499
201706 8.605 102.117 11.070
201709 10.698 102.717 13.682
201712 6.662 102.617 8.528
201803 1.588 102.917 2.027
201806 8.385 104.017 10.589
201809 6.115 104.718 7.671
201812 7.886 104.217 9.940
201903 2.910 104.217 3.668
201906 4.850 105.718 6.027
201909 6.424 106.018 7.960
201912 9.090 105.818 11.284
202003 -2.573 105.718 -3.197
202006 7.737 106.618 9.533
202009 6.274 105.818 7.789
202012 -0.649 105.518 -0.808
202103 -13.835 107.518 -16.903
202106 6.806 108.486 8.241
202109 9.554 109.435 11.468
202112 8.090 110.384 9.628
202203 -4.447 113.968 -5.126
202206 6.170 115.760 7.002
202209 7.170 118.818 7.927
202212 6.912 119.345 7.608
202303 -16.151 122.402 -17.333
202306 -0.496 123.140 -0.529
202309 7.589 124.195 8.027
202312 18.887 123.773 20.045
202403 -10.599 125.038 -11.135
202406 7.205 125.882 7.519
202409 6.278 126.198 6.535
202412 15.332 127.041 15.854
202503 -5.697 127.779 -5.857
202506 2.569 128.412 2.628
202509 3.743 129.255 3.804
202512 14.972 129.361 15.204
202603 -9.575 131.258 -9.583
202606 0.130 131.364 0.130

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of zł20.30 mean?
Bayer AG (WAR:BAY) has a Cyclically Adjusted FCF per Share of zł20.30 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Bayer AG and its competitors.
Is Bayer AG's Cyclically Adjusted FCF per Share too high?
Bayer AG's current Cyclically Adjusted FCF per Share is zł20.30. Overall, Bayer AG has a GF Score™ of 41/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bayer AG's Cyclically Adjusted FCF per Share compare to LLY and JNJ?
Bayer AG's Cyclically Adjusted FCF per Share of zł20.30 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Bayer AG and its competitors. Bayer AG's current Cyclically Adjusted FCF per Share is zł20.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bayer AG stock overvalued right now?
Based on GuruFocus' analysis, Bayer AG (WAR:BAY) is currently considered Significantly Overvalued. The stock's GF Value™ is zł114.86, compared to a current price of zł212.40 — trading 84.9% above its estimated fair value. The current Cyclically Adjusted FCF per Share is zł20.30. Bayer AG's overall GF Score™ is 41/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Bayer AG (WAR:BAY), the current Cyclically Adjusted FCF per Share is zł20.30 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bayer AG (WAR:BAY) Overvalued in 2026?

Based on GuruFocus' analysis, Bayer AG stock appears to be overvalued. The current stock price of zł212.40 is trading 84.9% above its estimated GF Value™ of zł114.86. GuruFocus considers Bayer AG to be Significantly Overvalued.

Key valuation signals for WAR:BAY:

  • Cyclically Adjusted FCF per Share: zł20.30
  • GF Value™: zł114.86 vs. price of zł212.40 (84.9% above fair value)
  • GF Score™: 41/100 with 3 warning signs

No single metric tells the full story. See the WAR:BAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bayer AG Business Description

Address Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs (about 38% of total sales in 2025) as well as vitamins and other consumer healthcare products (13% of total). The firm's crop science business (47% of total) sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.
41GF Score

Get the complete analysis for WAR:BAY

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł212.40
Price
zł114.86
GF Value